Skip to main content
logo
Obsidian Therapeutics, Inc. (OBX)
NASDAQ: OBX · Real-Time Price · USD
35.00
+7.50 (27.27%)
At close: Aug 10, 2026, 4:00 PM EDT
35.70
+0.70 (2.00%)
After-hours: Aug 10, 2026, 6:18 PM EDT

Obsidian Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Net Income
-95.25-100.61-83.11
Depreciation & Amortization
1.451.481.53
Loss (Gain) From Sale of Investments
-2-2.61-2.21
Stock-Based Compensation
8.288.937.06
Other Operating Activities
-0.16-0.14-0.03
Change in Accounts Payable
0.04-1.810.7
Change in Other Net Operating Assets
-0.384.361.05
Operating Cash Flow
-88.04-90.39-75
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Capital Expenditures
-0.02-0.07-0.78
Investment in Securities
75.5381.09-53.1
Investing Cash Flow
75.5281.02-53.87

Financing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Issuance of Common Stock
0.060.022.55
Other Financing Activities
---0.53
Financing Cash Flow
0.060.02162.52

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Net Cash Flow
-12.46-9.3633.64

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Free Cash Flow
-88.06-90.47-75.78
Free Cash Flow Growth
---
Free Cash Flow Per Share
-1189.85-1848.92-
Levered Free Cash Flow
--52.94-
Unlevered Free Cash Flow
--52.94-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Change in Working Capital
-0.342.561.75
SEC Filings: 10-K · 10-Q